Review of the final report of the 1998 Working Party on definition, nomenclature and diagnosis of hepatic encephalopathy.
about
Branched-chain amino acids for people with hepatic encephalopathyBranched-chain amino acids for people with hepatic encephalopathyCurrent pathogenetic aspects of hepatic encephalopathy and noncirrhotic hyperammonemic encephalopathyDefinition and nomenclature of hepatic encephalopathyMultimodality magnetic resonance imaging in hepatic encephalopathy: an updateUtility values for specific hepatic encephalopathy health states elicited from the general public in the United Kingdom.Prognostic indicators for acute liver failure development and mortality in patients with hepatitis A: consecutive case analysis.Multi-dimensional MR spectroscopy: towards a better understanding of hepatic encephalopathy.p53-targeted LSD1 functions in repression of chromatin structure and transcription in vivoClinical characteristics of patients with hepatocellular carcinoma in a middle eastern populationPredictive Factors of Spontaneous Bacterial Peritonitis Caused by Gram-Positive Bacteria in Patients With Cirrhosis.Rifaximin for treatment of hepatic encephalopathy.Serum 25-hydroxyvitamin D deficiency and hepatic encephalopathy in chronic liver disease.Minimal hepatic encephalopathy: consensus statement of a working party of the Indian National Association for Study of the Liver.Astrocyte glutamine synthetase: importance in hyperammonemic syndromes and potential target for therapyAdvances in the evaluation and management of minimal hepatic encephalopathy.Role of astrocytes in brain function and disease.Review article: the design of clinical trials in hepatic encephalopathy--an International Society for Hepatic Encephalopathy and Nitrogen Metabolism (ISHEN) consensus statement.Branched-chain amino acids for people with hepatic encephalopathy.Hepatic encephalopathy: An approach to its multiple pathophysiological features.Economic impact of the use of rifaximin 550 mg twice daily for the treatment of overt hepatic encephalopathy in Italy.Two-dimensional MR spectroscopy of minimal hepatic encephalopathy and neuropsychological correlates in vivo.Improvement in survival associated with embolisation of spontaneous portosystemic shunt in patients with recurrent hepatic encephalopathy.Urinary ammonia excretion increases acutely during living donor liver transplantation.Incidence of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt (TIPS) according to its severity and temporal grading classification.Minimal hepatic encephalopathy.
P2860
Q24187134-B1C097CD-F0DB-4216-8DE2-518582364748Q24187960-509A7044-E22A-4CB0-9BE1-568590B7A313Q27003171-466E27A7-00FC-4ADE-8181-3BBE5943F64BQ27023733-450D6432-3AD2-470B-9F3C-A5396C36248FQ30846419-C012C39E-9BA4-48C7-8A93-7F3A6DEE1A7AQ33805568-8BA6788B-EE7D-454E-AEEF-BF1B5A34FA0BQ33822584-FEED828F-162E-4433-8EB2-3179EF31F522Q35235287-928FBECD-BD27-4B92-8B19-546C270D98EFQ36846083-AE196015-8B11-4F04-9910-CBF8F863BB30Q37067779-AA72CB98-61BC-4553-BC54-35F6E94DD0B9Q37206442-5911B350-4D55-4371-9890-F447494E6924Q37353572-EA26D313-8071-4121-82CC-4DF3B58BB800Q37748014-459DCF1F-A91F-42B1-B7F6-82A9FD85503AQ37769273-FC814AA6-17C8-422B-93BD-60B6B061988BQ37794394-3A69DD8F-1259-49EE-AA13-CD86EB8A8C7AQ37798193-12CC2C08-698D-49CF-BBD4-24095912F26BQ37809408-9427D5F9-9B97-4D3D-AF06-0968A7A61E12Q37838478-2B30B7EC-F8D5-465E-B0B5-8D4D3F47F2E2Q38778053-714BADBC-B9E3-4B36-AFCB-C10DB01B10AFQ41813389-4A39AAB3-FC23-415C-B820-02F18EAD16C7Q42283125-3B5D298D-25D6-4245-BFBE-9FD2A0B7103AQ43005782-6A6967F4-E212-4029-BC36-6F6A7858497DQ43993187-68A64387-AAFA-43C3-ADA2-8B7B7DFFE912Q44147974-5AF873D9-2ED6-4DAE-88D7-333388002F84Q48649297-4752239D-8936-4D9B-ACF8-E88272ED3F80Q53101224-14B96266-7C93-4744-B556-D49BB4955A10
P2860
Review of the final report of the 1998 Working Party on definition, nomenclature and diagnosis of hepatic encephalopathy.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Review of the final report of ...... sis of hepatic encephalopathy.
@ast
Review of the final report of ...... sis of hepatic encephalopathy.
@en
type
label
Review of the final report of ...... sis of hepatic encephalopathy.
@ast
Review of the final report of ...... sis of hepatic encephalopathy.
@en
prefLabel
Review of the final report of ...... sis of hepatic encephalopathy.
@ast
Review of the final report of ...... sis of hepatic encephalopathy.
@en
P2860
P1476
Review of the final report of ...... sis of hepatic encephalopathy.
@en
P2093
P2860
P356
10.1111/J.1746-6342.2006.03216.X
P407
P478
25 Suppl 1
P577
2007-02-01T00:00:00Z